Ochiai, Atsushi
National Cancer Center Japan,
Japan
2025 Rank: 67988
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2771 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67988 | 71164 |
| Total Cites | 26020 | 29215 |
| H-index | 83 | 88 |
| Hm-index | 28 | 30 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 408 | 501 |
| Number of Single+First+Last Authored Papers | 276 | 276 |
| Total Cites to Single+First+Last Authored Papers | 11251 | 12397 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 22515 | 24332 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.20 |
| Self-Citation Percentage |
10.94%
|
|
Ochiai, Atsushi
National Cancer Center Hospital East,
Japan
2024 Rank: 65888
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2738 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65888 | 67959 |
| Total Cites | 24524 | 27522 |
| H-index | 79 | 85 |
| Hm-index | 28 | 29 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 402 | 494 |
| Number of Single+First+Last Authored Papers | 276 | 276 |
| Total Cites to Single+First+Last Authored Papers | 10705 | 11815 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 21205 | 22924 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.20 |
| Self-Citation Percentage |
10.89%
|
|
Ochiai, Atsushi
National Cancer Center Hospital East,
Japan
2023 Rank: 46784
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2054 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46784 | 49823 |
| Total Cites | 24369 | 27408 |
| H-index | 80 | 85 |
| Hm-index | 29 | 30 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 728 | 846 |
| Number of Single+First+Last Authored Papers | 303 | 303 |
| Total Cites to Single+First+Last Authored Papers | 10434 | 11545 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 20987 | 22727 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
11.09%
|
|
Ochiai, Atsushi
National Cancer Center Japan,
Japan
2022 Rank: 44272
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 1963 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44272 | 47329 |
| Total Cites | 22600 | 25476 |
| H-index | 77 | 82 |
| Hm-index | 28 | 29 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 712 | 830 |
| Number of Single+First+Last Authored Papers | 299 | 299 |
| Total Cites to Single+First+Last Authored Papers | 9705 | 10775 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 19460 | 21108 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
11.29%
|
|
Ochiai, Atsushi
National Cancer Center Tokyo,
Japan
2021 Rank: 46812
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2070 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46812 | 49613 |
| Total Cites | 21042 | 23743 |
| H-index | 75 | 80 |
| Hm-index | 27 | 28 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 690 | 806 |
| Number of Single+First+Last Authored Papers | 270 | 270 |
| Total Cites to Single+First+Last Authored Papers | 9039 | 10088 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18180 | 19723 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.20 |
| Self-Citation Percentage |
11.38%
|
|
Ochiai, Atsushi
National Cancer Center Tokyo,
Japan
2020 Rank: 45731
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2090 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45731 | 49056 |
| Total Cites | 19248 | 21749 |
| H-index | 71 | 76 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 674 | 791 |
| Number of Single+First+Last Authored Papers | 270 | 270 |
| Total Cites to Single+First+Last Authored Papers | 8269 | 9248 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16577 | 18003 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
11.50%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.